The conference will be hosted by Roswell Park Cancer Institute June 23-24, at the Queen's Landing, Niagara-on-the-Lake, Ontario, Canada. Formal sessions begin Friday, June 23, at 8:15 a.m.

More than 200 practitioners from the fields of medical, surgical and pediatric hematology/oncology, radiation oncology, counseling, clinical research and other health care specialties are expected to participate in discussions of risk facts, genetic markers of susceptibility, screening and interventions to decrease the risk of the most common second malignant neoplasms in these survivors -- acute leukemia and cancers of the breast, thyroid and skin.

"This exchange of ideas will increase our understanding of the complications of treatment and enable us to provide optimum quality of life for cancer survivors," said Daniel M. Green, MD, of the Department of Pediatrics at RPCI and conference chairman. "Further, it will contribute to general medical knowledge and assist primary caregivers in the management of their patients."

Formal sessions featuring an invited faculty on "Breast Cancer," moderated by Jimmie Holland, MD, Memorial Sloan-Kettering Cancer Center, New York, NY; "Leukemia" moderated by David Poplack, MD, Baylor College of Medicine, Houston, TX; "Skin Cancer," moderated by Leslie Robison, PhD, University of Minnesota, Minneapolis, MN; and "Thyroid Cancer," moderated by Sarah Donaldson, MD, Stanford University Medical Center, Stanford, CA; will be supplemented by 25 oral and 62 poster presentations in these areas submitted by researchers worldwide.

Roswell Park Cancer Institute, founded in 1898, is the nation's first cancer research, treatment and education center, and is the only National Cancer Institute-designated comprehensive cancer center in Western New York.

[Contact: Deborah Pettibone]

16-Jun-2000